✦ LIBER ✦

O-216 Phase III trial comparing cisplatin (CDDP) plus weekly vinorelbine (VNR) and CDDP plus day 1+8 VNR schedules in advanced non small cell lung cancer (NSCLC)

✍ Scribed by Gebbia, Vittorio; Galetta, Domenico; Caruso, Michele; Lorusso, Vito; Durini, Ernesto; Valenza, Roberto; Valerio, Maria R.; Colucci, Giuseppe

Book ID: 118571606
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 348 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91874-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-090 Weekly vinorelbine plus cisplatin

O-090 Weekly vinorelbine plus cisplatin versus day 1+8 vinorelbine withcisplatin in advanced non small cell lung cancer: End results of a phase III trial

✍ Gebbia, V.; Galetta, D.; Caruso, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Cisplatin plus weekly vinorelbine versus

Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: A prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale)

✍ GEBBIA, V; GALETTA, D; LORUSSO, V; CARUSO, M; VERDERAME, F; PEZZELLA, G; BORSELL 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 453 KB

The final results of a randomized phase

The final results of a randomized phase III trial comparing irinotecan (CPT-11) and cisplatin (CDDP) with vindesine (VDS) and CDDP in advanced non-small cell lung cancer (NSCLC)

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Vinorelbine (VNR) plus best supportive c

Vinorelbine (VNR) plus best supportive care (BSC) vs. BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (PTS). Results of a phase III randomized trial

✍ Gridelli, C; Ianniello, GP; Maiorino, L; Brancaccio, L; Cigolari, S; Bilancia, D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 229 KB

O-088 Phase III randomized trial compari

O-088 Phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C) for advanced non-small cell lung cancer (NSCLC): Analyses of elderly patients

✍ Belani, C.; Ramalingam, S.; Perry, M.; LaRocca, R.; Rinaldi, D.; Gable, P.; Test 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Multicentre randomised phase III study c

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer

✍ A. Martoni; A. Marino; F. Sperandi; S. Giaquinta; F. Di Fabio; B. Melotti; M. Gu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 333 KB